3 completed, 1 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Noha Mansour: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients Placebo, famotidine and loratadine - Breast Cancer, Filgrastim Adverse Reaction | Phase 1 / Phase 2 | Completed | Noha Mansour | 58 | 2024-02-01 | 2024-12-13 |
| Midodrine Effect on the Mortality Rates in Septic Shock Patients Midodrine Oral Tablet - Septic Shock | Phase 2 | Completed | Noha Mansour | 100 | 2022-11-07 | 2025-03-03 |
| The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock Ondansetron, Placebo - Sepsis, Septic Shock | Phase 1 / Phase 2 | Unknown | Noha Mansour | 40 | 2022-04-24 | 2023-03-15 |
| Montelukast Use in Rheumatoid Arthritis Montelukast, Placebo, Conventional DMARDs - Rheumatoid Arthritis | Phase 2 | Completed | Noha Mansour | 92 | 2021-12-15 | 2024-02-13 |
Shock, Septic (2) · Arthritis, Rheumatoid (1) · Breast Neoplasms (1) · Sepsis (1)
Famotidine (1) · Loratadine (1) · Midodrine (1) · Ondansetron (1) · montelukast (1)
Egypt (4)